10 Best Healthcare Technology Stocks To Watch For 2014

Ever-expanding Liberty Media (NASDAQ: LMCA  ) posted a nearly $1 billion year-over-year revenue gain this quarter, but it still fell short of the Street's desires. On top of that, the company saw net income decline by two-thirds. Does this mean investors should shun the majority owner of Sirius XM Radio? Not at all. Liberty remains a highly compelling business run by some of the best minds in the industry. As the big media landscape continues to shift amid technological disruption, Liberty is likely to remain one of the most aggressive businesses available to investors. With the recent earnings report in mind, let's take a closer look.

Looking back
Despite a substantial rise in revenue, Liberty Media took a hit on Tuesday due to a sharp cut in bottom-line earnings. Earning just�$76 million in net income, the company was faced with high costs. Still, there is much for investors to celebrate in the company's latest quarter.

Liberty's chief property, Sirius XM, achieved�record revenue of $962 million. Adjusted EBITDA, also at a record level, rose to $296 million. Liberty sold back 500 million of its shares to Sirius, earning the company a nice early profit on its massive investment.

Best Quality Stocks To Watch Right Now: PIMCO Intermediate Municipal Bond Strategy Fund (MUNI)

PIMCO Intermediate Municipal Bond Strategy Fund, formerly, PIMCO Intermediate Municipal Bond ETF (the Fund), seeks to achieve its investment objective by investing at least 80% of its assets in a diversified portfolio of debt securities whose interest is, in the opinion of bond counsel for the issuer at the time of issuance, exempt from federal income tax (Municipal Bonds). Municipal Bonds are issued by or on behalf of states and local governments and their agencies, authorities and other instrumentalities. The Fund may only invest in the United States dollar-denominated investment grade debt securities, rated Baa or higher by Moody��, or equivalently rated by S&P or Fitch. It may invest 25% or more of its total assets in Municipal Bonds that finance similar projects, such as those relating to education, health care, housing, transportation and utilities. The Fund�� investment advisor is Pacific Investment Management Company LLC (PIMCO). Advisors' Opinion:

• [By Mary Anne & Pamela Aden]

  The ones we like best and recommend buying are the iShares 20+ year Treasury Bond (TLT), the iShares 10-20 year Treasury Bond (TLH), Proshares Ultra 20+ year Treasury (UBT) and Pimco Intermediate Muni Bond strategy ETF (MUNI).

10 Best Healthcare Technology Stocks To Watch For 2014: Sunshine Heart Inc (SSH)

Sunshine Heart, Inc., incorporated on August 22, 2002, is an early-stage medical device company focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. As of December 31, 2011, the Company was in the process of obtaining regulatory approvals necessary to sell its product.

The Company has developed tools to allow the C-Pulse to be implanted through a small pacemaker-like incision between the patient�� ribs and sternum rather than a sternotomy. Patients implanted through its minimally invasive procedure require a hospital stay of four to seven days in connection with implantation of the C-Pulse System, after which they return home. During the year ended December 31, 2011, the Company completed enrollment and implantation of 20 patients in the North American feasibility phase of its trial. In April 2011, the Food and Drug Administration (FDA) approved an expansion protocol to allow the Company to implant up to 20 additional patients and add two additional centers to its feasibility study.

The Company competes with Thoratec Corporation, HeartWare International Inc., CircuLite, Inc., CardioKinetix, Inc., AbioMed, Inc., Jarvik Heart, Inc., MicroMed Technology, Inc., SynCardia Systems, Inc., Terumo Heart, Inc., WorldHeart Corporation in the United States and Europe, and Berlin Heart GmbH in Europe.

Advisors' Opinion:

• [By John Udovich]

  Small cap heart stocks Sunshine Heart Inc (NASDAQ: SSH), Abiomed, Inc (NASDAQ: ABMD) and AtriCure Inc (NASDAQ: ATRC) each find different ways go to the heart of the problem for cardiac�patients and have all been good performers for investors this year. After all and according to statistics collected by the CDC, heart disease is the leading cause of death for both men and women as about 600,000 people die of heart disease in the United States every year���accounting�for 1 in every 4 deaths. Moreover, roughly 715,000 Americans have a heart attack every year and�ff these, 525,000 are a first heart attack and 190,000 happen to people who have already had one. In other words, there is a big market for the following small cap heart stocks to address:

10 Best Healthcare Technology Stocks To Watch For 2014: Accenture plc. (ACN)

Accenture plc provides management consulting, technology, and business process outsourcing services worldwide. It offers various management consulting services in the areas of finance and enterprise performance, operations, risk management, sales and customer service, strategy, sustainability, and talent and organization management, as well as provides industry-specific management consulting services. The company also offers system integration consulting services and solutions, including enterprise solutions and enterprise resource planning, industry and functional solutions, information management services, custom solutions, and Microsoft solutions; and technology consulting services and solutions comprising information technology (IT) strategy, infrastructure consulting, IT security consulting, and application modernization and optimization. In addition, it provides technology outsourcing services, which include application outsourcing services; infrastructure outsourcin g services in service desk, workplace, data-center, network, security, and IT spend management service areas; cloud computing services; and mobility and embedded software services. Further, the company provides business process outsourcing (BPO) services for business functions and/or processes, including finance and accounting, human resources, learning and procurement, and others, as well as industry-specific BPO services, such as credit services. It serves communications, electronics and high technology, media and entertainment, banking, capital markets, insurance, health, public service, airlines, freight and logistics, automotive, consumer goods and service, industrial equipment, infrastructure and transportation service, life sciences, retail, chemical, energy, natural resources, and utility industries. Accenture plc has a strategic collaboration with Marriott International, Inc. The company was founded in 1995 and is based in Dublin, Ireland.

Advisors' Opinion:

• [By Reuters]

  U.S. Department of Health and Human Services/AP WASHINGTON -- The federal government will end its contract with CGI Federal for the error-plagued HealthCare.gov website, instead signing a contract with Accenture, The Washington Post reported Friday in its online edition. U.S.-listed shares of CGI Group (GIB), the parent of CGI Federal, were down 3.5 percent at $31.36 in late trading on the New York Stock Exchange. HealthCare.gov's technology failures in the weeks after its Oct. 1 launch created a political crisis for President Barack Obama, threatening the rollout of his signature health care law to consumers and emboldening its foes among Republican lawmakers to call for its delay. CGI has been immersed in the effort to repair the site, which began working more smoothly for hundreds of thousands of consumers in December, allowing them to enroll in new health insurance plans offered under Obama's Affordable Care Act. But the government's dissatisfaction over the website's early crash, as well as aspects of the site that still do not work, are behind plans to sign a one-year contract with Accenture (ACN) instead, the Post report said, quoting a person familiar with the matter. CGI's current contract for the work ends in late February, and the new 12-month agreement with Accenture is valued at about $90 million, the Post said. In an emailed statement, an Accenture spokesman said, "We are in discussions with clients and prospective clients all the time -- but it is not appropriate to discuss new business opportunities we may or may not be pursuing." Officials at CGI weren't immediately available for comment. The Center for Medicare and Medicaid Services, the government agency overseeing the health-reform law's rollout, wouldn't confirm or deny that it planned to end its contract with CGI. "We are working with our contract partners to make a mutually agreed upon transition to ensure that HealthCare.gov continues to operate smoothly for consumers," a CMS s

10 Best Healthcare Technology Stocks To Watch For 2014: Sempra Energy(SRE)

Sempra Energy, together with its subsidiaries, develops new energy infrastructure, operates utilities, and provides energy-related products and services worldwide. It operates in six segments: SDG&E, SoCalGas, Sempra Generation, Sempra Pipelines & Storage, Sempra LNG (liquefied natural gas), and Sempra Commodities. The SDG&E segment has electric and natural gas franchises that locate, operate, and maintain facilities for the transmission and distribution of electricity and natural gas to residential, commercial, industrial, street and highway lighting, and direct access customers. The SoCalGas segment has natural gas franchises that locate, operate, and maintain facilities for the transmission and distribution of natural gas to electric generation, wholesale, large commercial, industrial, and enhanced oil recovery customers. The Sempra Generation segment involves in the generation and wholesale distribution of electricity through a fleet of natural gas-fired power generati on facilities in Arizona, Nevada, and Indiana, as well as Mexico with a total capacity of 2,513 megawatts. The Sempra Pipelines & Storage segment operates 1,883 miles of distribution pipelines, 224 miles of transmission pipelines, and 3 compressor stations in Mexico; operates Mobile Gas, a natural gas distribution utility located in Mobile and Baldwin counties in Alabama; and operates natural gas storage facilities in Washington County of Alabama and Simpson County of Mississippi. The Sempra LNG segment involves in the receipt, storage, and vaporization of LNG, as well as the purchase and sale of natural gas. It operates Energia Costa Azul LNG receipt terminal in Baja California, Mexico, as well as Cameron LNG receipt terminal in Hackberry, Louisiana. The Sempra Commodities segment engages in the commodities-marketing business. Sempra Energy has operations in the United States, Canada, Mexico, Argentina, Chile, and Peru. The company was founded in 1998 and is headquartered i n San Diego, California.

Advisors' Opinion:

• [By Marc Bastow]

  California-based utility holding company Sempra Energy (SRE) raised its quarterly dividend 5% to 66 cents per share, payable April 15 to shareholders of record as of March 27.
  SRE Dividend Yield: 2.80%

• [By Rich Duprey]

  Utility operator�Sempra Energy (NYSE: SRE  ) announced yesterday its second-quarter dividend of $0.63 per share, the same rate it paid last quarter after raising the payout 5% from $0.60 per share.

10 Best Healthcare Technology Stocks To Watch For 2014: Intralinks Holdings Inc (IL)

IntraLinks Holdings, Inc. (IntraLinks), incorporated in June 1996, together with its subsidiaries, is a global provider of Software-as-a-Service (SaaS) solutions for securely managing content, exchanging critical business information and collaborating within and among organizations. The Company�� cloud-based solutions enable organizations to control, track, search and exchange time-sensitive information inside and outside the firewall, all within a secure environment. The Company provide services to enterprises and governmental agencies in over 60 countries across a variety of industries, including financial services, pharmaceutical, biotechnology, consumer, energy, industrial, legal, insurance, real estate and technology. The Company sells its solutions directly through an enterprise sales team with industry-specific expertise and indirectly through a customer referral network and channel partners. In April 2013, it acquired MergerID. Concurrently, IntraLinks acquired PE-Nexus LLC.

The Company delivers its solutions through a cloud-based model where they are available on-demand over the Internet using a multi-tenant SaaS architecture in which a single instance of its software serves all of its customers. The Company provides its customers with various services, including access to its cloud-based IntraLinks Platform, access to one or more of its intraLinks exchanges, and related customer support and other services.

The Company competes with Merrill Corporation, RR Donnelley & Sons Company, EMC Corporation and International Business Machines Corp. (IBM).

Advisors' Opinion:

• [By Lee Jackson]

  IntraLinks Holdings Inc. (NYSE: IL) is a leading global software as a service (SaaS) provider of inter-enterprise content management and collaboration solutions. It recently launched Intralinks DealNexus, the largest global deal marketplace and professional network for qualified mergers and acquisitions (M&A) professionals. Intralinks DealNexus offers a secure and confidential way for dealmakers to find and engage the best buyers or capital partners, and it is used by more than 5,000 private equity firms, corporations, investment banks and advisors to intelligently connect and exchange deal opportunities. Wunderlich rates the company a stock to buy and has a $17 price objective. The consensus target is $12.The stock closed on Friday at $8.61.

10 Best Healthcare Technology Stocks To Watch For 2014: British American Tobacco PLC (BATS)

British American Tobacco p.l.c. (British American Tobacco) is a holding company. The Company�� four principal brands include Dunhill, Kent, Lucky Strike and Pall Mall. The Company has many other famous international and local brands, including Rothmans, Vogue, Viceroy, Kool, Peter Stuyvesant and Benson & Hedges. The Company�� brands are sold in over 180 markets. The Company�� products include Cigarettes, Smokeless snus and Cigars. The Company has over 44 cigarette factories in 39 countries. In addition to cigarettes, the Company makes cigarillos, roll your own and pipe tobacco. Advisors' Opinion:

• [By Namitha Jagadeesh]

  European stocks advanced for a fifth day, their longest rally this year, as data showed the U.K. avoided a triple-dip recession and as companies including British American Tobacco Plc (BATS) reported results.

10 Best Healthcare Technology Stocks To Watch For 2014: ViroPharma Incorporated(VPHM)

ViroPharma Incorporated, a biotechnology company, develops and commercializes therapeutic products that address serious diseases in the United States and internationally. It focuses on developing products used by physician specialists or in hospital settings. The company markets and sells Cinryze, a C1 esterase inhibitor therapy for the routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema, a life-threatening genetic disorder; and Vancocin HCl capsule, an oral capsule formulation for the treatment of C. difficile-associated diarrhea (CDAD) and to treat enterocolitis caused by staphylococcus aureus, including methicillin-resistant strains. It also offers Plenadren, an orphan drug for treatment of adrenal insufficiency in adults; Buccolam, a oromucosal solution for treatment of prolonged, acute, and convulsive seizures in infants, toddlers, children, and adolescents; and maribavir, an antiviral compound for the treatment o f CMV disease through a license agreement with GlaxoSmithKline. The company?s primary development programs include Cinryze, a C1 esterase inhibitor for management of hereditary angioedema; and VP 20621, a non-toxigenic strain of C. difficile. Its clinical stage drug candidate comprises VP-20629 for the treatment of Friedreich?s Ataxia. The company sells its products directly to wholesale drug distributors and specialty pharmacies/distributors. ViroPharma Incorporated was founded in 1994 and is headquartered in Exton, Pennsylvania.

Advisors' Opinion:

• [By Max Macaluso and David Williamson]

  At the end of last week, a Bloomberg article revealed that Shire (NASDAQ: SHPG  ) and pharmaceutical giant Sanofi� (NYSE: SNY  ) may be circling ViroPharma� (NASDAQ: VPHM  ) . The the following video, from The Motley Fool's health care show Market Checkup, analysts David Williamson and Max Macaluso take a close look at ViroPharma and discuss the recent interest in this small biotech company.

• [By Paul Ausick]

  Stocks on the Move: ViroPharma Inc. (NASDAQ: VPHM) is up 25.4% at $49.38 on a $4.2 billion buyout offer from London-listed Shire. Zalicus Inc. (NASDAQ: ZLCS) is down 72.3% at $1.30 on a failed drug trial.

• [By Sara Sjolin]

  Shares of Shire (UK:SHP) �climbed 0.9% in London after the drug maker said it is buying rare-disease company ViroPharma Inc. (VPHM) �for $4.2 billion, or $50 a share. ViroPharma shares traded 26% higher in the U.S.